BCM, Duke University to Study Surgery Treatment for Mesothelioma
November 09, 2023
November 09, 2023
HOUSTON, Texas, Nov. 9 (TNSres) -- The Baylor College of Medicine issued the following news:
Mesothelioma is a highly fatal disease with a survival rate of under 10% at five years. New advances with immunotherapy have improved survival, but only 23% of patients are alive at three years when treated with immunotherapy alone. Surgery with chemotherapy has resulted in the longest survival. Baylor College of Medicine and Duke University will conduct a clinical trial for patients with me . . .
Mesothelioma is a highly fatal disease with a survival rate of under 10% at five years. New advances with immunotherapy have improved survival, but only 23% of patients are alive at three years when treated with immunotherapy alone. Surgery with chemotherapy has resulted in the longest survival. Baylor College of Medicine and Duke University will conduct a clinical trial for patients with me . . .